Kainate treatment alters TGF-β3 gene expression in the rat hippocampus

Molecular Brain Research

Volumn 108, Issue 1-2, 2002, Pages 60-70

  Kim, Hyoung Chun ^a   Bing, Guoying ^b   Kim, Seong Jin ^c   Jhoo, Wang Kee ^a   Shin, Eun Joo ^a   Wie, Myung Bok ^a   Ko, Kwang Ho ^d   Kim, Won Ki ^e   Flanders, Kathleen C ^c   Choi, Shin Geon ^a   Hong, Jau Shyong ^f  

^a Kangwon National University   (South Korea)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Seoul National University   (South Korea)

^e Ewha Womans University School of Medicine   (South Korea)

^f NONE

Author keywords

Astrocyte; Exogenous TGF 3; Hippocampus; Kainic acid; Neurodegeneration; Transforming growth factor 3

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; KAINIC ACID; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA3; AMINO ACID RECEPTOR STIMULATING AGENT; NEUROPROTECTIVE AGENT; TGFB3 PROTEIN, RAT; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; ASTROCYTE; CELL POPULATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE EXPRESSION; GRANULE CELL; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; ANIMAL; ANIMAL BEHAVIOR; CELL SIZE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; FISCHER 344 RAT; GENETICS; GLIA; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY; SEIZURE;

ANIMALS; BEHAVIOR, ANIMAL; CELL SIZE; EXCITATORY AMINO ACID AGONISTS; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; KAINIC ACID; MALE; NEUROGLIA; NEUROPROTECTIVE AGENTS; RATS; RATS, INBRED F344; SEIZURES; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA3;

EID: 1842865315     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(02)00514-4     Document Type: Article

References (56)

1. Aronica E., Vliet E.A.V., Mayboroda O., Troost D., Lopes da Silva F.H., Gorter J.A. Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy. Eur. J. Neurosci. 12:2000;2333-2344.
2. Bing G., Wilson B., Hudson P., Jin L., Zhang W., Bing R., Hong J.S. A single dose of kainic acid elevates the levels of enkephalines and activator protein-1 transcription factors in the hippocampus for up to 1 year. Proc. Natl. Acd. Sci. USA. 94:1997;9422-9427.
3. Chirgwin J.M., Przybyla A.E., MacDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
4. Church G.M., Gilbert W. Genomic sequencing. Proc. Natl. Acad. Sci. USA. 81:1984;1991-1995.
5. Clark W.G., Vivonia C.A., Baxter C.F. Accurate free hand injections into the lateral brain ventricle of the conscious mouse. J. Appl. Physiol. 25:1968;319-321.
6. Da Cunha A., Vitkvic L. TGF-β1 expression and regulation in rat cortical astrocytes. J. Neuroimmunol. 36:1992;157-169.
7. Denhez F., Lafyatis R., Kondaiah P., Roberts A.B., Sporn M.B. Cloning by polymerase chain reaction of a new mouse TGF-β, TGF-β 3. Growth Factors. 3:1990;139-146.
8. Derynck R., Lindquist P.B., Lee A., Wen D., Tamm J., Graycar J.L., Rhee L., Mason A.J., Miller D.A., Coffey R.J., Moses H.L., Chen E.Y. A new type of transforming growth factor-β, TGF-β3. EMBO J. 7:1998;3737-3743.
9. Endoh M., Pulsinelli W.A., Wagner J.A. Transient global ischemia induces dynamic changes in the expression of bFGF and the FGF receptor. Mol. Brain Res. 22:1994;76-88.
10. Finch C.E., Laping N.J., Morgan T.E., Nicols N.R., Pasinetti G.M. TGF-β1 is an organizer of responses to neurodegeneration. J. Cell. Biochem. 53:1993;314-322.
11. Flanders K.C., Ludecke G., Engels S., Cissel D.S., Roberts A.B., Kondaiah P., Lafyatis R., Sporn M.B., Unsicker K. Localization and actions of transforming growth factor-βs in the embryonic nervous system. Development. 113:1991;183-191.
12. Flanders K.C., Lüdecke G., Renzig J., Hamm C., Cissel D., Unisicker K. Effects of TGF-βs and bFGF on astroglial cell growth and gene expression in vitro. Mol. Cell. Neurosci. 4:1993;406-417.
13. Flanders K.C., Lippa C.F., Smith T.W., Pollen D.A., Sporn M.B. Altered expression of transforming growth factor-β in Alzheimer's disease. Neurology. 45:1995;1561-1569.
14. Flanders K.C., Bhandiwad A.R., Winokur T.S. Transforming growth factor-βs block cytokine induction of catalase and xanthine oxidase mRNA levels in cultured rat cardiac cells. J. Mol. Cell. Cardiol. 29:1997;273-280.
15. Flanders K.C., Ren R., Lippa C.F. Transforming growth factor-βs in neurodegenerative disease. Prog. Neurobiol. 54:1998;71-85.
16. Fort P., Marty L., Piechaczyk M., Sabrouty E., Dani C., Jeanteur P., Blanchard J.M. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate dehydrogenase multigenic family. Nucleic Acids Res. 13:1985;1431-1442.
17. Foster A.C., Mena E.E., Monaghan D.T., Cotman C.W. Synaptic localization of kainic acid binding sites. Nature. 289:1981;73-75.
18. Graycar J.L., Miller D.A., Arrick B.A., Lyons R.M., Moses H.L., Derynck R. Human transforming growth factor-β3: recombinant expression, purification and biological activities in comparison with transforming growth factor-β1 and β2. Mol. Endocrinol. 7:1989;1977-1986.
19. Gross C.E., Bednar M.M., Howard D.B., Sporn M.B. Transforming growth factor-β1 reduces infarct size after experimental cerebral ischemia in a rabbit model. Stroke. 24:1993;558-562.
20. Hahm K.B., Cho K., Lee C., Im Y.H., Chang J., Choi S.G., Sorensen P.H.B., Thiele C.J., Kim S.J. Repression of the gene encoding the TGF-β type II receptor is a major target of the EWS-FLI1 oncoprotein. Nature Genet. 23:1999;222-227.
21. Hong J.S., McGinty J.F., Lee P.H.K., Xie C.W., Michell C.L. Relationship between hippocampal opioid peptides and seizures. Prog. Neurobiol. 40:1993;507-538.
22. Hunter K.E., Sporn M.B., Davies A.M. Transforming growth factor-βs inhibit mitogen-stimulated proliferation of astrocytes. Glia. 7:1993;203-211.
23. Jørgensen M.B., Finsen B.R., Jensen M.B., Castellano B., Diemer N.H., Zimmer J. Microglial and astroglial reaction to ischemic and kainic-acid-induced lesions of the adult rat hippocampus. Exp. Neurol. 120:1993;70-88.
24. Kim H.C., Bing G., Jhoo W.K., Ko K.H., Kim W.K., Lee D.C., Shin E.J., Hong J.S. Dextromethorphan modulates the AP-1 DNA-binding activity induced by kainic acid. Brain Res. 824:1999;125-132.
25. Kim H.C., Bing G., Jhoo W.K., Ko K.H., Kim W.K., Suh J.H., Kim S.J., Kato K., Hong J.S. Changes of hippocampal Cu/Zn superoxide dismutase after kainate treatment in the rat. Brain Res. 853:2000;215-226.
26. Kim H.C., Jhoo W.K., Kim W.K., Suh J.H., Shin E.J., Kato K., Ko K.H. An immunocytochemical study of mitochondrial manganese- superoxide dismutase in the rat hippocampus after kainate administration. Neurosci. Lett. 281:2000;65-68.
27. Kim H.C., Bing G., Jhoo W.K., Kim W.K., Shin E.J., Park E.S., Choi Y.S., Lee D.W., Shin C.Y., Ryu J.R., Ko K.H. Oxidative damage causes formation of lipofuscin-like substances in the hippocampus of the senescence-accelerated mouse after kainate treatment. Behav. Brain Res. 131:2002;211-220.
28. Kim S.J., Jeang K.T., Glick A.B., Sporn M.B., Robert A.B. Promotor sequences of the human transforming growth factor-β 1 gene responsive to transforming growth factor-β 1 autoinduction. J. Biol. Chem. 264:1989;7041-7045.
29. Kim S.J., Park K., Koeller D., Kim K.Y., Wakefield L.M., Sporn M.B., Roberts A.B. Post-transcriptional regulation of the human transforming growth factor-β1 gene. J. Biol. Chem. 267:1992;13702-13707.
30. Knuckey N., Finch P., Thompson N., Palm D., Primiano M., Johnson C.E., Flanders K.C., Sporn M. The pattern of neuronal expression and the neuroprotective role of transforming growth factor β isoforms following transient cerebral ischemia. FASEB J. 8:1994;A654.
31. Knuckey N.W., Finch P., Palm D.E., Primiano M.J., Johanson C.E., Flanders K.C., Thompson N.L. Differential neuronal and astrocytic expression of transforming growth factor β isoforms in rat hippocampus following transient forebrain ischemia. Mol. Brain Res. 40:1996;1-14.
32. Koketsu N., Berlove D.J., Moskowitz M.A., Kowall N.W. Pretreatment with intraventricular basic fibroblast growth factor decreases infarct size following focal cerebral ischemia in rats. Ann. Neurol. 35:1994;451-457.
33. Lafyatist R., Lechleider R., Kim S.J., Jakowlew S., Roberts A.B., Sporn M.B. Structural and functional characterization of the transforming growth factor β3 promoter; a cAMP-responsive element regulates basal and induced transcription. J. Biol. Chem. 265:1990;19128-19136.
34. Lassmann H., Petsche U., Kitz K., Baran H., Sperk G., Seitelberger F., Hornykiewicz O. The role of brain edema in epileptic brain damage induced by systemic kainic acid injection. Neuroscience. 13:1984;691-704.
35. Lothman E.W., Collins R.C. Kainic acid induced limbic seizures: metabolic, behavioral, electroencephalographic and neuropathological correlates. Brain Res. 218:1981;299-318.
36. Lyons R.M., Moses H.L. Transforming growth factors and the regulation of cell proliferation. Eur. J. Biochem. 187:1990;467-473.
37. Lindholm D., Castren E., Kiefer R., Zafra F., Thoenen H. Transforming growth factor-β 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J. Cell. Biol. 117:1992;395-400.
38. Miller D.A., Lee A., Matsui Y., Chen E.Y., Moses H.L., Derynck R. Complementary DNA cloning of the murine transforming growth factor β3 (TGFβ3) precusor and the comparative expression of TGFβ3 and TGFβ1 messenger RNA in murine embryos and adult tissues. Mol. Endocrinol. 3:1989;1926-1934.
39. Miller D.A., Lee A., Pelton R.W., Chen E.Y., Moses H.L., Derynck R. Murine transforming growth factor-β2 cDNA sequence and expression in adult tissues and embryos. Mol. Endocrinol. 3:1989;1108-1114.
40. Miller D.A., Pelton R.W., Derynck R., Moses H.L. Transforming growth factor β: a family of growth regulatory peptides. Ann. NY Acad. Sci. 593:1990;208-217.
41. Morgan T.E., Nichols N.R., Pasinetti G.M., Finch C.E. TGF-β1 mRNA increases in macrophage/microglial cells of the hippocampus in response to deafferentation and kainic acid-induced neurodegeneration. Exp. Neurol. 120:1993;291-301.
42. Morganti-Kossmann M.C., Kossmann T., Brandes M.E., Mergenhagen S.E., Whal S.M. Autocrine and paracrine regulation of astrocyte function by transforming growth factor-β J. Neuroimmunol. 39:1992;163-173.
43. Nadler J.V., Perry B.W., Gentry C., Cotman C.W. Degeneration of hippocampal CA3 pyramidal cells induced by intraventricular kainic acid. J. Comp. Neurol. 192:1980;333-359.
44. Ohta M., Greenberger J.S., Anklesaria P., Bassols A., Massague J. Two forms of transforming growth factor-β distinguished by multipotential hematopoietic progenitor cells. Nature (Lond.). 329:1987;539-541.
45. Prehn J.H.M., Backhaus C., Krieglstein J. Transforming growth factor-β1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neocortex from ischemic injury in vivo. J. Cereb. Blood Flow Metab. 13:1993;521-525.
46. Prehn J.H.M., Bindokas V.P., Marcuccilli C.J., Krajewski J., Reed J.C., Miller R.J. Regulation of neuronal Bcl 2 protein expression and calcium homeostasis by transforming growth factor type β confers wide-ranging protection on rat hippocampus neurons. Proc. Natl. Acad. Sci. USA. 91:1994;12599-12603.
47. Racine R.J. Modification of seizure activity by electrical stimulation: motor seizure. EEG Clin. Neurophysiol. 32:1972;281-294.
48. Roberts A.B., Kim S.J., Kondaiah P., Jakowlew S.B., Denhez F., Glick A.B., Geiser A.G., Watanabe S., Noma T., Lechleider R., Sporn M.B. Transcriptional control of expression of the TGF-βs. Ann. NY Acad. Sci. 593:1990;43-50.
49. Seubert T., Lee K., Lynch G. Ischemia triggers NMDA receptor-linked cytoskeletal proteolysis in hippocampus. Brain Res. 492:1989;366-370.
50. Shigeno T., Mina T., Takakura K., Graham D.I., Kato G., Hashimoto Y., Furukawa S. Amelioration of delayed neuronal death in the hippocampus by nerve growth factor. J. Neurosci. 11:1991;2194-2919.
51. Sperk G., Lassmann H., Baran H., Kish S.J., Seitelberger F., Hornykiewicz O. Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience. 10:1983;1301-1315.
52. Streit W.J. An improved staining method for rat microglial cells using the lectin from Griffonia simplicifolia (GSAI-B4). J. Histochem. Cytochem. 38:1990;1683-1686.
53. ten Dijke P., Hansen P., Iwata K.K., Pieler C., Foulkers J.G. Identification of another member of transforming growth factor type β gene family. Proc. Natl. Acad. Sci. USA. 85:1988;4715-4719.
54. Thompson N.L., Flanders K.C., Smith J.M., Ellingsworth L.R., Roberts A.B., Sporn M.B. Expression of transforming growth factor-β1 in specific cells and tissues of adult and neonatal mice. J. Cell. Biol. 108:1989;661-669.
55. Unsicker K., Flanders K.C., Cissel D.S., Lafyatis R., Sporn M.B. Transforming growth factors β isoforms in the adult rat central and peripheral nervous system. Neuroscience. 44:1991;613-625.
56. Wilson J.X. Antioxidant defense of the brain: a role for astrocytes. Can. J. Physiol. Pharmacol. 75:1997;1149-1163.